# Amanda Gillon

> Amanda Gillon is a post-ipo equity investor at BioScience Managers Limited backing Medical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioScience Managers Limited](https://shizune.co/investors/profile/bioscience-managers-limited)
- Location: Melbourne, Australia
- Total investments: 1
- Last investment: May 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/amanda-gillon-a1256921

Amanda Gillon is a post-ipo equity investor at BioScience Managers Limited in Melbourne focused on Medical and Wellness. Amanda has over seven years of life science experience with close familiarity with plant biotechnology and human protein folding diseases.She holds a PhD in Molecular Biology and Biochemistry from La Trobe University together with the agri-biotechnology company Hexima Ltd., focusing on a family of novel circular proteins (cyclotides) thatpossess potent biopharmaceutical properties.Since completing her PhD, Amanda worked for three years as a research scientist at Columbia University in New York City identifying new genetic and biochemical pathways that may be directly relevant to a number of human diseases, most notably cystic fibrosis. Amanda has recently been involved in a number of biotechnology commercialization groups.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Wellness | 1 | 100% |
| Health Care | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adherium | Adherium (previously known as Nexus6) is a privately owned developer and manufacturer of solutions that help patients and their healthcare professionals monitor and increase patient adherence to prescribed therapies, leading to improved disease management and reduced healthcare costs. | $3.3M | Post-IPO Equity | May 26, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [New Zealand Growth Capital Partners](https://shizune.co/investors/profile/new-zealand-growth-capital-partners) — VC Fund, 1 deal together

## About BioScience Managers Limited

VC Fund · Melbourne, Australia

BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.

5 contacts available at BioScience Managers Limited.

| Name | Title | Profile |
| --- | --- | --- |
| Amanda Gillon | Investment Analyst | https://shizune.co/investors/profile/amanda-gillon |
| Matt McNamara | Managing Director | https://shizune.co/investors/profile/matt-mcnamara |
| Nora Frey | Investment Manager | https://shizune.co/investors/profile/nora-frey |
| Bronwyn Dilley | senior executive | https://shizune.co/investors/profile/bronwyn-dilley |
| Jeremy Curnock Cook | Manager | https://shizune.co/investors/profile/jeremy-curnock-cook |

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Amanda Gillon invest in?

Amanda Gillon invests primarily in Medical, Wellness and Health Care startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Amanda Gillon last invest?

The most recent investment recorded for Amanda Gillon closed in May 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co